On Sep 5,
) broadcasted a live lung isolation surgery to demonstrate the
efficacy of its latest Rusch EZ-Blocker Endobronchial Blocker.
This device was developed as a superior alternative to
traditional double-lumen endobronchial tubes and single balloon
ECHO THERAPEUT (ECTE): Free Stock Analysis
GIVEN IMAGING (GIVN): Get Free Report
LUMINEX CORP (LMNX): Free Stock Analysis
TELEFLEX INC (TFX): Free Stock Analysis
To read this article on Zacks.com click here.
According to an Anesthesiology journal, bronchial blockers can
overcome many of the drawbacks of double-lumen endobronchial
tubes, like the increased risk for airway trauma, when compared
to single-lumen endotracheal tubes. Yet another medical journal
had highlighted the inefficiency of the single-cuff endobronchial
blockers, explaining why such devices receive limited acceptance
The EZ-Blocker Endobronchial Blocker has a unique Y-shaped
distal, matching the bifurcation of the trachea, which allows for
the intuitive placement of the balloons in the right or left
bronchus. Moreover, it can be securely placed at the carina
without any navigation assistance, thereby enhancing clinical
The broadcast was hosted from an operating room at Radbound
University Nijmegen Medical Centre, The Netherlands, to educate
clinicians across the globe regarding the benefits of the new
EZ-Blocker Endobronchial Blocker. This marketing initiative by
Teleflex should help boost the product's popularity in the
international markets, going forward.
TFX is a global leader in supply of medical devices used in
critical care and surgery. The company focuses on profitable and
consistent growth and expects its sales growth to surpass market
growth in the long run. It also plans to gain market share in key
However, the company operates in a highly competitive medical
devices industry and stringent regulatory environment. The demand
for its products is susceptible to healthcare reimbursement
systems in the domestic as well as the international market.
TFX has a Zacks Rank #3 (Hold). While we remain on the sidelines
regarding this company, other medical instruments stocks that are
worth considering include
). All these stocks carry a Zacks Rank #2 (Buy).